Shares of Veradigm Inc. (NASDAQ:MDRX - Get Free Report) traded up 9.3% during trading on Friday . The stock traded as high as $8.38 and last traded at $8.25. 27,013 shares changed hands during trading, a decline of 99% from the average session volume of 3,978,436 shares. The stock had previously closed at $7.55.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on the stock. Royal Bank of Canada decreased their price objective on shares of Veradigm from $22.00 to $11.00 and set an "outperform" rating on the stock in a research report on Friday, January 19th. StockNews.com assumed coverage on shares of Veradigm in a research report on Monday. They set a "hold" rating on the stock. Barclays assumed coverage on shares of Veradigm in a research report on Wednesday, January 3rd. They set an "equal weight" rating and a $11.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a $10.00 price objective (down from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Veradigm presently has an average rating of "Hold" and a consensus target price of $11.25.
Read Our Latest Stock Analysis on Veradigm
Veradigm Stock Up 0.7 %
The firm's 50 day simple moving average is $7.79 and its 200 day simple moving average is $10.12.
Hedge Funds Weigh In On Veradigm
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Quarry LP bought a new position in Veradigm during the first quarter valued at approximately $37,000. TFO Wealth Partners LLC boosted its stake in Veradigm by 105,280.0% during the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker's stock valued at $52,000 after buying an additional 5,264 shares during the last quarter. Gladius Capital Management LP boosted its stake in Veradigm by 135.0% during the fourth quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker's stock valued at $66,000 after buying an additional 3,587 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in Veradigm by 95.0% during the second quarter. Tower Research Capital LLC TRC now owns 5,310 shares of the software maker's stock valued at $67,000 after buying an additional 2,587 shares during the last quarter. Finally, Envestnet Asset Management Inc. boosted its stake in Veradigm by 27.4% during the first quarter. Envestnet Asset Management Inc. now owns 32,691 shares of the software maker's stock valued at $69,000 after buying an additional 7,027 shares during the last quarter.
Veradigm Company Profile
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
